Atrial Fibrillation Clinical Trial
Official title:
The Value of Amino-Terminal Brain Natriuretic Peptide and C-Reactive Protein Serum Levels for Predicting Recurrence of Atrial Fibrillation and/or Atrial Flutter After Radiofrequency Catheter Ablation
Catheter ablation using radiofrequency is a new therapeutic tool to treat atrial
fibrillation with a higher success rate than medical therapy (80% versus less than 50%
respectively). Because of the length of the intervention and of the risk of complications of
the procedure, it would be important to determine success rate before the intervention. The
information gained from this study will in all probability improve our estimation of the
chances of a successful intervention and may enable us to take necessary therapeutic
measures in case of an elevated risk of recurrence.
Multiple studies suggest that the 2 markers in this study could provide information of this
nature, however, their utility in the radiofrequency catheter ablation treatment of atrial
fibrillation has never been demonstrated.
Catheter ablation of atrial fibrillation is a recent therapeutic tool to treat atrial
fibrillation. The success rate of eliminating atrial fibrillation by radiofrequency catheter
ablation is 80 %, after one or sometimes two procedures, against 20-50 % with drug
treatment.
This intervention may be complicated by : hematoma at the puncture site – 1 % incidence;
thromboembolic events < 1 % incidence; cardiac perforation with tamponade < 1 %, pulmonary
vein stenosis 2 % incidence.
The aim of this study is to evaluate blood tests of biological products (NT-proBNP and CRP)
as markers of prognosis and success after radiofrequency catheter ablation for atrial
fibrillation.
Previous studies demonstrated the prognostic value of NT-proBNP and CRP in the recurrence of
atrial fibrillation after electrical cardioversion. However the prognostic value of these
biomarkers was never demonstrated in the setting of radiofrequency catheter ablation of
atrial fibrillation.
This is an observation study including 180 patients with the indication of catheter ablation
for atrial fibrillation. Confounding factors of increased NT-proBNP will be assessed with
echocardiographic imaging.
;
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
| Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
| Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
| Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
| Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
| Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
| Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
| Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
| Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
| Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
| Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
| Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
| Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
| Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
| Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
| Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |